Position in ABBV
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$869,919
-$1,214,070 QoQ
Shares Held
3,457
-63.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#2,675
of 4,153 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Park Edge Advisors, LLC holds $9,575,115 across 7 Drug Manufacturers - General names. ABBV ranks #4 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,584 | $4,211,838 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
10,590 | $1,337,940 | |
| 3 | LLY |
ELI LILLY & Co
|
1,061 | $1,272,595 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
3,457 | $869,919 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
14,381 | $828,633 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,378 | $562,573 | |
| 7 | PFE |
Pfizer Inc
|
20,416 | $491,617 |
All Filings in ABBV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $869,919 | 3,457 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $2,083,989 | 9,582 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,114,217 | 9,253 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,356,592 | 5,859 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $700,158 | 3,772 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $790,309 | 3,772 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $696,939 | 3,922 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $774,319 | 3,921 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $672,529 | 3,921 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $759,539 | 4,171 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $677,373 | 4,371 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,172,953 | 7,869 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $649,937 | 4,824 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $768,800 | 4,824 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $855,078 | 5,291 | Shares | Sole | 2023-04-14 | |
| No filing history on record for this holder in this stock. | ||||||